NewsBenzingaFDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies Benzinga 2026.10.19 15:13 (GMT+0) Open on Benzinga Other news Alpha Teknova Shares Sink 23% After Hours: Here's Why Stock Futures Rise as Investors Focus on Earnings from SpaceX and Other Companies - TipRanks.com Ashford Hospitality Trust (AHT) Shares Rocket 66% After Hours: What’s Behind the Surge? Elon Musk Says SPCX Could Reach Up to $1 Trillion ARR By 2027—Gwynne Shotwell Says Starlink Is Contracted for 12,000 Aircraft Rocket Lab Stock Gains As Earnings Date Is Set, Wall Street Price Targets Signal Triple-Digit Upside SpaceX Can't Find Spare Nvidia, Google or Amazon Chips Despite Billions to Spend, Strategist Terms It 'Pretty Insane'
Elon Musk Says SPCX Could Reach Up to $1 Trillion ARR By 2027—Gwynne Shotwell Says Starlink Is Contracted for 12,000 Aircraft
SpaceX Can't Find Spare Nvidia, Google or Amazon Chips Despite Billions to Spend, Strategist Terms It 'Pretty Insane'
